Effectiveness and Safety of Dabigatran Reversal with Idarucizumab in the Taiwanese Population: A Comparison Based on Eligibility for Inclusion in Clinical Trials

Jhih Wei Dai, Chien Ho Wang, Chan Lin Chu, Shu Chen Liao*

*Corresponding author for this work

Research output: Contribution to journal › Journal Article › peer-review

4 Scopus citations

Fingerprint

Dive into the research topics of 'Effectiveness and Safety of Dabigatran Reversal with Idarucizumab in the Taiwanese Population: A Comparison Based on Eligibility for Inclusion in Clinical Trials'. Together they form a unique fingerprint.

Pharmacology, Toxicology and Pharmaceutical Science